The emergence of PET/MR imaging has been solidly underway for a few years and the combination of the two modalities represents significant improvements to PET alone, namely MR’s excellent soft-tissue contrast and ability to capture not only physiologic but also biochemical and metabolic data. A review in the March issue of The Journal of Nuclear Medicine presents an updated perspective on how PET/MR is moving forward.